[1]
ShresthaS.B., BhusalM., JwarchanJ., GautamS. and ShresthaP.R. 2023. Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients. Journal of Nepal Health Research Council. 20, 4 (Jul. 2023), 881-885. DOI:https://doi.org/10.33314/jnhrc.v20i4.4233.